Characteristics of patients with asthma overprescribed short-acting beta-agonist (SABA) reliever inhalers stratified by blood eosinophil count in North East London: a cross-sectional observational study

Background: Overprescription of short-acting beta-agonist (SABA) inhalers and blood eosinophil count have strong associations with exacerbation risk in asthma. However, in the authors' recent publication only a minority of patients overprescribed SABA (≥6 inhalers in 12 months) were eosinophilic (≥0.3 x 109 cells/l). Aim: To compare the characteristics of eosinophilic and non-eosinophilic patients with asthma overprescribed SABA inhalers, and identify latent classes using clinical variables available in primary care. Design & setting: Cross-sectional analysis of patients with asthma in Nor... Mehr ...

Verfasser: Paul Pfeffer
Hajar Hajmohammadi
James Cole
Chris Griffiths
Sally Hull
Anna De Simoni
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: BJGP Open, Vol 7, Iss 2 (2023)
Verlag/Hrsg.: Royal College of General Practitioners
Schlagwörter: asthma / short-acting beta-agonist / albuterol / primary health care / general practice / Medicine (General) / R5-920
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27281258
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3399/BJGPO.2023.0020